Loading
Total declarations
Companies
▲ Purchases (37 ops.)
▼ Sales (36 ops.)
Latest filing published 04 Mar 2026 for Zevia PBC, €49k.
Filing timeline
BuySalePadraic L. Spence
Insider track record
Disclosed buys
37
Disclosed sells
36
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Padraic L. Spence: trading record in brief
Padraic L. Spence, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Zevia PBC and Physicians Formula Holdings, Inc. The record holds 85 filings, for trades running from 3 June 2009 to 3 March 2026.
In open-market terms, that means 37 purchases worth €126k on one side and 36 sales worth €3.4M on the other. Netting one side against the other leaves €3.3M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 1 sale.
In size, the median ticket on the buying side is €2,342.
The newest entry dates from 4 March 2026: an open-market sale of €49k, in Zevia PBC. The latest purchase dates back some time: it was published 6,155 days ago, on 17 December 2009. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Padraic L. Spence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
40,000 shares@ US$1.43791.7% of flowClass A Common StockSEC:0001462709-26-000002:0
200,000 shares@ US$2.643915.9% of flowClass A Common StockSEC:0001462709-25-000002:0
34,722 shares0Class A Common StockSEC:0001415889-25-017448:0
75,000 shares@ US$2.71027.6% of flowClass A Common StockSEC:0001415889-25-012940:0
118,455 shares0Class A Common StockSEC:0001462709-24-000005:0
36,300 shares@ US$1.02411.4% of flowClass A Common StockSEC:0001462709-24-000004:0
26,199 shares@ US$1.32091.3% of flowClass A Common StockSEC:0001462709-24-000002:0
27,170 shares@ US$1.57911.6% of flowClass A Common StockSEC:0001209191-24-001988:0
32,342 shares@ US$1.91942.4% of flowClass A Common StockSEC:0001209191-23-059420:0
32,345 shares@ US$2.16672.7% of flowClass A Common StockSEC:0001209191-23-056300:0
32,546 shares@ US$1.8752.4% of flowClass A Common StockSEC:0001209191-23-053232:0
32,295 shares@ US$2.56463.9% of flowClass A Common StockSEC:0001209191-23-050021:0
33,261 shares@ US$2.48163.2% of flowClass A Common StockSEC:0001209191-23-047498:0
32,104 shares@ US$4.12924.9% of flowClass A Common StockSEC:0001209191-23-042723:0
31,749 shares@ US$4.68575.6% of flowClass A Common StockSEC:0001209191-23-039154:0
18,359 shares0Class A Common StockSEC:0001209191-23-038554:0
11,109 shares@ US$3.93241.7% of flowClass A Common StockSEC:0001209191-23-032981:0
18,952 shares@ US$3.43822.5% of flowClass A Common StockSEC:0001209191-23-025229:0
19,111 shares@ US$3.57492.6% of flowClass A Common StockSEC:0001209191-23-021605:0
21,767 shares@ US$4.37513.7% of flowClass A Common StockSEC:0001209191-23-013003:0
9,818 shares@ US$4.48951.7% of flowClass A Common StockSEC:0001209191-23-004326:0
19,989 shares@ US$3.73752.9% of flowClass A Common StockSEC:0001209191-22-062491:0
33,893 shares@ US$3.5344.8% of flowClass A Common StockSEC:0001209191-22-058411:0
33,130 shares@ US$3.53444.9% of flowClass A Common StockSEC:0001209191-22-054172:0
33,396 shares@ US$4.47276.2% of flowClass A Common StockSEC:0001209191-22-050936:0
25 of 35 declarations
